Avoro Capital Advisors LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 87 filers reported holding RELMADA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$29,929,000
-44.3%
935,000
-38.7%
0.52%
-43.8%
Q1 2021$53,695,000
+9.8%
1,525,0000.0%0.93%
+10.1%
Q4 2020$48,907,000
-13.3%
1,525,000
+1.7%
0.84%
+5.0%
Q3 2020$56,430,000
-11.5%
1,500,000
+5.3%
0.80%
-36.4%
Q2 2020$63,769,000
+62.6%
1,425,000
+23.9%
1.26%
-4.8%
Q1 2020$39,227,0001,150,0001.32%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders